The RASSF1A tumor suppressor

RASSF1A (Ras association domain family 1 isoform A) is a recently discovered tumor suppressor whose inactivation is implicated in the development of many human cancers. Although it can be inactivated by gene deletion or point mutations, the most common contributor to loss or reduction of RASSF1A function is transcriptional silencing of the gene by inappropriate promoter methylation. This epigenetic mechanism can inactivate numerous tumor suppressors and is now recognized as a major contributor to the development of cancer. RASSF1A lacks apparent enzymatic activity but contains a Ras association (RA) domain and is potentially an effector of the Ras oncoprotein. RASSF1A modulates multiple apoptotic and cell cycle checkpoint pathways. Current evidence supports the hypothesis that it serves as a scaffold for the assembly of multiple tumor suppressor complexes and may relay pro-apoptotic signaling by K-Ras.

[1]  Dominic P. Kwiatkowski,et al.  Haplotype mapping of the bronchiolitis susceptibility locus near IL8 , 2004, Human Genetics.

[2]  L. Hesson,et al.  The RASSF1A Tumor Suppressor Activates Bax via MOAP-1* , 2006, Journal of Biological Chemistry.

[3]  A. Giuliano,et al.  Distinct Hypermethylation Profile of Primary Breast Cancer Is Associated with Sentinel Lymph Node Metastasis , 2005, Clinical Cancer Research.

[4]  G. Clark,et al.  A Role for the RASSF1A Tumor Suppressor in the Regulation of Tubulin Polymerization and Genomic Stability , 2004, Cancer Research.

[5]  J. Mann,et al.  Frequent epigenetic inactivation of the RASSF1A tumor suppressor gene in Hodgkin's lymphoma , 2004, Oncogene.

[6]  Chun Xing Li,et al.  Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3 , 2000, Nature Genetics.

[7]  J. Avruch,et al.  Regulation of the MST1 kinase by autophosphorylation, by the growth inhibitory proteins, RASSF1 and NORE1, and by Ras. , 2004, The Biochemical journal.

[8]  L. Hesson,et al.  CpG island promoter hypermethylation of a novel Ras-effector gene RASSF2A is an early event in colon carcinogenesis and correlates inversely with K-ras mutations , 2005, Oncogene.

[9]  J. Minna,et al.  Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. , 2001, Journal of the National Cancer Institute.

[10]  G. Pfeifer,et al.  The Tumor Suppressor RASSF1A Does not Interact with Cdc20, an Activator of the Anaphase-Promoting Complex , 2007, Cell cycle.

[11]  A. Protopopov,et al.  The RASSF1A tumor suppressor gene is inactivated in prostate tumors and suppresses growth of prostate carcinoma cells. , 2002, Cancer research.

[12]  A. Bell,et al.  Ras Uses the Novel Tumor Suppressor RASSF1 as an Effector to Mediate Apoptosis* , 2000, The Journal of Biological Chemistry.

[13]  G. Pfeifer,et al.  Epigenetic inactivation of the Ras-association domain family 1 (RASSF1A) gene and its function in human carcinogenesis. , 2003, Histology and histopathology.

[14]  F. McCormick,et al.  Signaling Specificity by Ras Family GTPases Is Determined by the Full Spectrum of Effectors They Regulate , 2004, Molecular and Cellular Biology.

[15]  W. Reik,et al.  Frequent RASSF1A tumour suppressor gene promoter methylation in Wilms' tumour and colorectal cancer , 2002, Oncogene.

[16]  A. Chan,et al.  Frequent hypermethylation of promoter region of RASSF1A in tumor tissues and voided urine of urinary bladder cancer patients , 2003, International journal of cancer.

[17]  G. Wiche,et al.  Novel Features of the Light Chain of Microtubule-associated Protein MAP1B: Microtubule Stabilization, Self Interaction, Actin Filament Binding, and Regulation by the Heavy Chain , 1998, The Journal of cell biology.

[18]  J. Fagin,et al.  The RAS oncogene induces genomic instability in thyroid PCCL3 cells via the MAPK pathway , 2000, Oncogene.

[19]  R. Xavier,et al.  Identification of a Novel Ras-Regulated Proapoptotic Pathway , 2002, Current Biology.

[20]  D. Ellison,et al.  Epigenetic inactivation of the RASSF1A tumour suppressor gene in ependymoma. , 2005, Cancer letters.

[21]  Y. Shiloh.  ATM and related protein kinases: safeguarding genome integrity , 2003, Nature Reviews Cancer.

[22]  J. Minna,et al.  Promoter Hypermethylation Profile of Ovarian Epithelial Neoplasms , 2005, Clinical Cancer Research.

[23]  Y. Tomizawa,et al.  Epigenetic inactivation of RASSF1A candidate tumor suppressor gene at 3p21.3 in brain tumors , 2003, Oncogene.

[24]  B J Williams,et al.  Comparative genomic hybridization. , 1996, Methods in molecular medicine.

[25]  J. Avruch,et al.  Regulation of the MST 1 kinase by autophosphorylation , by the growth inhibitory proteins , RASSF 1 and NORE 1 , and by Ras , 2004 .

[26]  J. Grill,et al.  Methylation of RASSF1A and TRAIL pathway-related genes is frequent in childhood intracranial ependymomas and benign choroid plexus papilloma. , 2006, Cancer genetics and cytogenetics.

[27]  M. Ohira,et al.  Aberrant methylation of RASGRF 2 and RASSF 1 A in human non-small cell lung cancer , 2022 .

[28]  J. Avruch,et al.  RASSF3 and NORE1: identification and cloning of two human homologues of the putative tumor suppressor gene RASSF1 , 2002, Oncogene.

[29]  S. Law,et al.  Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma. , 2006, International journal of oncology.

[30]  Hongtao Yu,et al.  Cdc20: a WD40 activator for a cell cycle degradation machine. , 2007, Molecular cell.

[31]  E. Zabarovsky,et al.  High frequency somatic mutations in RASSF1A in nasopharyngeal carcinoma , 2005, Cancer biology & therapy.

[32]  R. Youle,et al.  Control of mitochondrial permeability by Bcl-2 family members. , 2004, Biochimica et biophysica acta.

[33]  S. Nishizuka,et al.  RASSF2, a potential tumour suppressor, is silenced by CpG island hypermethylation in gastric cancer , 2005, British Journal of Cancer.

[34]  A. Tannapfel,et al.  Allele loss and epigenetic inactivation of 3p21.3 in malignant liver tumors , 2005, International journal of cancer.

[35]  D. Sidransky,et al.  The RASSF 1 A Tumor Suppressor Gene Is Commonly Inactivated in Adenocarcinoma of the Uterine Cervix , 2003 .

[36]  S. Halpain,et al.  The MAP1 family of microtubule-associated proteins , 2006, Genome Biology.

[37]  Jianbin Huang,et al.  The Hippo Signaling Pathway Coordinately Regulates Cell Proliferation and Apoptosis by Inactivating Yorkie, the Drosophila Homolog of YAP , 2005, Cell.

[38]  G. Pfeifer,et al.  Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma. , 2003, Cancer research.

[39]  M. You,et al.  Tumor susceptibility of Rassf1a knockout mice. , 2005, Cancer research.

[40]  E. Máthé.  RASSF1A, the new guardian of mitosis , 2004, Nature Genetics.

[41]  J. Minna,et al.  Inactivation of RASSF1C during in vivo tumor growth identifies it as a tumor suppressor gene , 2004, Oncogene.

[42]  R. Dammann,et al.  Identification of RASSF1A modulated genes in nasopharyngeal carcinoma , 2006, Oncogene.

[43]  J. Minna,et al.  The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. , 2000, Cancer research.

[44]  X. Qian,et al.  RASSF1A and NORE1A methylation and BRAFV600E mutations in thyroid tumors , 2005, Laboratory Investigation.

[45]  M. Sheetz,et al.  Stabilization and functional modulation of microtubules by microtubule-associated protein 4. , 1998, The Biological bulletin.

[46]  B. Vogelstein,et al.  Candidate Tumor-Suppressor Genes , 2003 .

[47]  A. Knudson.  Mutation and cancer: statistical study of retinoblastoma. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[48]  J Downward,et al.  Ras signalling and apoptosis. , 1998, Current opinion in genetics & development.

[49]  Channing J Der,et al.  The dark side of Ras: regulation of apoptosis , 2003, Oncogene.

[50]  M. You,et al.  Tumor Susceptibility of Rassf 1 a Knockout Mice , 2004 .

[51]  I. Hickson,et al.  Caretaker tumour suppressor genes that defend genome integrity. , 2002, Trends in molecular medicine.

[52]  Kohzoh Imai,et al.  The Ras effector RASSF2 is a novel tumor-suppressor gene in human colorectal cancer. , 2005, Gastroenterology.

[53]  C. Plass,et al.  RASSF1A promoter methylation and Kras2 mutations in non small cell lung cancer. , 2003, Neoplasia.

[54]  K. Harvey,et al.  The Salvador–Warts–Hippo pathway — an emerging tumour-suppressor network , 2007, Nature Reviews Cancer.

[55]  H. Dralle,et al.  CpG island methylation of tumor-related promoters occurs preferentially in undifferentiated carcinoma. , 2006, Thyroid : official journal of the American Thyroid Association.

[56]  W. Yeo,et al.  High frequency of promoter hypermethylation of RASSF1A in tumorous and non‐tumourous tissue of breast cancer , 2005, Pathology.

[57]  S. T. Kim,et al.  Substrate Specificities and Identification of Putative Substrates of ATM Kinase Family Members* , 1999, The Journal of Biological Chemistry.

[58]  J. Minna,et al.  Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours , 2001, Oncogene.

[59]  R. Hofstra,et al.  Concomitant RASSF1A hypermethylation and KRAS/BRAF mutations occur preferentially in MSI sporadic colorectal cancer , 2005, Oncogene.

[60]  Jacqueline A. Hall,et al.  CpG island methylation of DNA damage response genes in advanced ovarian cancer. , 2005, Cancer research.

[61]  أشرف دلول.  RASSF1A Interacts with Microtubule-Associated Proteins and Modulates Microtubule Dynamics , 2004 .

[62]  H. Kajiho,et al.  Release of RASSF1C from the nucleus by Daxx degradation links DNA damage and SAPK/JNK activation , 2006, The EMBO journal.

[63]  J. Minna,et al.  Identification of the E1A-Regulated Transcription Factor p120E4F as an Interacting Partner of the RASSF1A Candidate Tumor Suppressor Gene , 2004, Cancer Research.

[64]  N. Copeland,et al.  Title Structure , Expression , and Chromosome Mapping of LATS 2 , a Mammalian Homologue of the Drosophila Tumor Suppressor Gene lats / warts , 2022 .

[65]  U. Pastorino,et al.  Identification of RASSF8 as a candidate lung tumor suppressor gene , 2006, Oncogene.

[66]  Su Jeong Song,et al.  The Centrosomal Protein RAS Association Domain Family Protein 1A (RASSF1A)-binding Protein 1 Regulates Mitotic Progression by Recruiting RASSF1A to Spindle Poles* , 2005, Journal of Biological Chemistry.

[67]  R. Schulte‐Hermann,et al.  NORE1B, a candidate tumor suppressor, is epigenetically silenced in human hepatocellular carcinoma. , 2006, Journal of hepatology.

[68]  K. Katagiri,et al.  RAPL, a Rap1-binding molecule that mediates Rap1-induced adhesion through spatial regulation of LFA-1 , 2003, Nature Immunology.

[69]  D. Sidransky,et al.  The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[70]  S. Thorgeirsson,et al.  Ubiquitous activation of Ras and Jak/Stat pathways in human HCC. , 2006, Gastroenterology.

[71]  R. Medema,et al.  Cyclin A Is a Mediator of p120E4F-Dependent Cell Cycle Arrest in G1 , 2001, Molecular and Cellular Biology.

[72]  Miki Ohira,et al.  Aberrant methylation of RASGRF2 and RASSF1A in human non-small cell lung cancer. , 2006, Oncology reports.

[73]  H. Geddert,et al.  Methylation of RAS association domain family protein 1A as a biomarker of lung cancer , 2006, Cancer.

[74]  K. Hofmann,et al.  A novel inter action motif, SARAH, connects three classes of tumor suppressor , 2003, Current Biology.

[75]  B. Goh,et al.  Analyses of promoter hypermethylation for RUNX3 and other tumor suppressor genes in nasopharyngeal carcinoma. , 2006, Anticancer research.

[76]  Su Jeong Song,et al.  The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC–Cdc20 complex , 2004, Nature Cell Biology.

[77]  K. Nasmyth,et al.  Whose end is destruction: cell division and the anaphase-promoting complex. , 1999, Genes & development.

[78]  G. Pfeifer,et al.  Hypermethylation of the CpG island of the RASSF1A gene in ovarian and renal cell carcinomas , 2001, International journal of cancer.

[79]  S. Hirohashi,et al.  Epigenetic instability and chromosomal instability in hepatocellular carcinoma. , 2006, The American journal of pathology.

[80]  Y. Yoo,et al.  RASSF1A suppresses the c-Jun-NH2-kinase pathway and inhibits cell cycle progression. , 2005, Cancer research.

[81]  M. Fraga,et al.  CpG island promoter hypermethylation of the Ras-effector gene NORE1A occurs in the context of a wild-type K-ras in lung cancer , 2004, Oncogene.

[82]  E. Maher,et al.  Frequent epigenetic inactivation of the RASSF1A tumour suppressor gene in testicular tumours and distinct methylation profiles of seminoma and nonseminoma testicular germ cell tumours , 2003, Oncogene.

[83]  L. Hesson,et al.  RASSF6 is a novel member of the RASSF family of tumor suppressors , 2007, Oncogene.

[84]  W. Mckeehan,et al.  Specificity of the methylation-suppressed A isoform of candidate tumor suppressor RASSF1 for microtubule hyperstabilization is determined by cell death inducer C19ORF5. , 2005, Cancer research.

[85]  Jan-Michael Peters,et al.  The anaphase-promoting complex: proteolysis in mitosis and beyond. , 2002, Molecular cell.

[86]  J. Minna,et al.  Clinicopathological significance of epigenetic inactivation of RASSF1A at 3p21.3 in stage I lung adenocarcinoma. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[87]  R. Benezra,et al.  Mitotic checkpoints: from yeast to cancer. , 2001, Current opinion in genetics & development.

[88]  C. Ricketts,et al.  Transcriptional regulation of cyclin A2 by RASSF1A through the enhanced binding of p120E4F to the cyclin A2 promoter. , 2005, Cancer research.

[89]  Kenichi Harada,et al.  Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines , 2002, Oncogene.

[90]  J. Herman,et al.  K-ras mutations and RASSF1A promoter methylation in colorectal cancer , 2002, Oncogene.

[91]  F. Al-Mulla,et al.  Depletion of the Ras association domain family 1, isoform A-associated novel microtubule-associated protein, C19ORF5/MAP1S, causes mitotic abnormalities. , 2007, Cancer research.

[92]  Jie-Oh Lee,et al.  Role of the tumor suppressor RASSF1A in Mst1-mediated apoptosis. , 2006, Cancer research.

[93]  M. Hasan,et al.  Differences in the regulation of microtubule stability by the pro‐rich region variants of microtubule‐associated protein 4 , 2006, FEBS letters.

[94]  A. Chan,et al.  Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers , 2003, International journal of cancer.

[95]  G. Clark,et al.  RASSF2 Is a Novel K-Ras-specific Effector and Potential Tumor Suppressor* , 2003, Journal of Biological Chemistry.

[96]  M. Nistal,et al.  Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma , 2006, BMC Cancer.

[97]  A. Protopopov,et al.  The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[98]  E. Cartwright,et al.  Novel Functional Interaction between the Plasma Membrane Ca2+ Pump 4b and the Proapoptotic Tumor Suppressor Ras-associated Factor 1 (RASSF1)* , 2004, Journal of Biological Chemistry.

[99]  G. Pfeifer,et al.  Methylation of the Tumor Suppressor Gene RASSF1A in Human Tumors , 2005, Biochemistry (Moscow).

[100]  Jonathan Chernoff,et al.  Apoptotic Phosphorylation of Histone H2B Is Mediated by Mammalian Sterile Twenty Kinase , 2003, Cell.

[101]  N. Tapon,et al.  The Drosophila RASSF Homolog Antagonizes the Hippo Pathway , 2006, Current Biology.

[102]  K. Hoang-Xuan,et al.  Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas , 2004, Oncogene.

[103]  Hong Zhou,et al.  Involvement of Ras Activation in Human Breast Cancer Cell Signaling, Invasion, and Anoikis , 2004, Cancer Research.

[104]  G. Pfeifer,et al.  Control of microtubule stability by the RASSF1A tumor suppressor , 2003, Oncogene.

[105]  L. Hesson,et al.  The Role of RASSF1A Methylation in Cancer , 2007, Disease markers.

[106]  M. Roncalli,et al.  Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer , 2006, British Journal of Cancer.

[107]  R. Medema,et al.  Cyclin A Is a Mediator of p 120 E 4 F-Dependent Cell Cycle Arrest in G 1 , 2001 .

[108]  Toshiaki Katada,et al.  Activation of the c-Jun N-Terminal Kinase Pathway by MST1 Is Essential and Sufficient for the Induction of Chromatin Condensation during Apoptosis , 2007, Molecular and Cellular Biology.

[109]  J. Avruch,et al.  The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1 , 2002, Oncogene.

[110]  M. Lerman,et al.  Epigenetic inactivation of RASSF1A in head and neck cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[111]  J. Minna,et al.  NORE1A, a homologue of RASSF1A tumour suppressor gene is inactivated in human cancers , 2003, Oncogene.

[112]  D. Ellison,et al.  Biallelic epigenetic inactivation of the RASSF1A tumor suppressor gene in medulloblastoma development. , 2002, Cancer research.

[113]  A. Protopopov,et al.  The RASSF 1 A Tumor Suppressor Gene Is Inactivated in Prostate Tumors and Suppresses Growth of Prostate Carcinoma Cells 1 , 2002 .

[114]  堀口 桂志.  Epigenetic inactivation of RASSF1A candidate tumor suppressor gene at 3p21.3 in brain tumors , 2004 .

[115]  L. Hutchins,et al.  Methylation Profiling of Archived Non–Small Cell Lung Cancer: A Promising Prognostic System , 2005, Clinical Cancer Research.

[116]  B. Ng,et al.  The RASSF1A Isoform of RASSF1 Promotes Microtubule Stability and Suppresses Tumorigenesis , 2005, Molecular and Cellular Biology.

[117]  Julian Downward,et al.  Identification of novel gene expression targets for the Ras association domain family 1 (RASSF1A) tumor suppressor gene in non-small cell lung cancer and neuroblastoma. , 2003, Cancer research.

[118]  W. Tao,et al.  Human homologue of the Drosophila melanogaster lats tumour suppressor modulates CDC2 activity , 1999, Nature Genetics.

[119]  C. Sardet,et al.  The E4F Protein Is Required for Mitotic Progression during Embryonic Cell Cycles , 2004, Molecular and Cellular Biology.

[120]  M. Hoque,et al.  A Quantitative Promoter Methylation Profile of Prostate Cancer , 2004, Clinical Cancer Research.

[121]  M. Sheikh,et al.  Tumor suppressor RASSF1A is a microtubule-binding protein that stabilizes microtubules and induces G2/M arrest , 2004, Oncogene.

[122]  R. Weichselbaum,et al.  Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma. , 2002, European journal of cancer.

[123]  J. Reilly,et al.  Aberrant methylation of the negative regulators RASSFIA, SHP‐1 and SOCS‐1 in myelodysplastic syndromes and acute myeloid leukaemia , 2005, British journal of haematology.

[124]  Walter Kolch,et al.  Mammalian sterile 20-like kinases in tumor suppression: an emerging pathway. , 2005, Cancer research.

[125]  L. Hesson,et al.  RASSF1A Interacts with Microtubule-Associated Proteins and Modulates Microtubule Dynamics , 2004, Cancer Research.

[126]  J. Avruch,et al.  Nore1 and RASSF1 regulation of cell proliferation and of the MST1/2 kinases. , 2006, Methods in enzymology.

[127]  J. Minna,et al.  Identification of the E 1 A-Regulated Transcription Factor p 120 E 4 F as an Interacting Partner of the RASSF 1 A Candidate Tumor Suppressor Gene , 2004 .

[128]  G. Clark,et al.  The Pro-apoptotic Ras Effector Nore1 May Serve as a Ras-regulated Tumor Suppressor in the Lung* , 2003, Journal of Biological Chemistry.

[129]  L. Hesson,et al.  Multigene methylation analysis of Wilms' tumour and adult renal cell carcinoma , 2003, Oncogene.

[130]  B. Neel,et al.  The tumor suppressor RASSF1A and MAP-1 link death receptor signaling to Bax conformational change and cell death. , 2005, Molecular cell.

[131]  Shing-Leng Chan,et al.  MAP-1, a Novel Proapoptotic Protein Containing a BH3-like Motif That Associates with Bax through Its Bcl-2 Homology Domains* , 2001, The Journal of Biological Chemistry.

[132]  Tsung-Teh Wu,et al.  Epigenetic alterations in neuroendocrine tumors: methylation of RAS-association domain family 1, isoform A and p16 genes are associated with metastasis , 2005, Modern Pathology.

[133]  P. Güntert,et al.  Structural insight into dimeric interaction of the SARAH domains from Mst1 and RASSF family proteins in the apoptosis pathway , 2007, Proceedings of the National Academy of Sciences.

[134]  J. Minna,et al.  The RASSF1A Tumor Suppressor Blocks Cell Cycle Progression and Inhibits Cyclin D1 Accumulation , 2002, Molecular and Cellular Biology.

[135]  M. Lerman,et al.  Epigenetic Inactivation of RASSF 1 A in Head and Neck Cancer 1 , 2003 .

[136]  C. Marsit,et al.  Carcinogen Exposure and Epigenetic Silencing in Bladder Cancer , 2006, Annals of the New York Academy of Sciences.

[137]  G. Pfeifer,et al.  RASSF1A Is Part of a Complex Similar to the Drosophila Hippo/Salvador/Lats Tumor-Suppressor Network , 2007, Current Biology.

[138]  J. Avruch,et al.  Identification of Nore1 as a Potential Ras Effector* , 1998, The Journal of Biological Chemistry.

[139]  G. Pfeifer,et al.  Involvement of the RASSF1A tumor suppressor gene in controlling cell migration. , 2005, Cancer research.

[140]  C. Eng,et al.  RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours , 2001, Oncogene.

[141]  R. Xavier,et al.  The Scaffold Protein CNK1 Interacts with the Tumor Suppressor RASSF1A and Augments RASSF1A-induced Cell Death* , 2004, Journal of Biological Chemistry.

[142]  C. Larsson,et al.  The t(1;3) breakpoint-spanning genes LSAMP and NORE1 are involved in clear cell renal cell carcinomas. , 2003, Cancer cell.

[143]  Nigel P Carter,et al.  Analysis of ovarian cancer cell lines using array‐based comparative genomic hybridization , 2005, The Journal of pathology.

[144]  F. Latif,et al.  Role of the Ras-association domain family 1 tumor suppressor gene in human cancers. , 2005, Cancer research.

[145]  L. Hesson,et al.  RASSF4/AD037 Is a Potential Ras Effector/Tumor Suppressor of the RASSF Family , 2004, Cancer Research.

[146]  W. Tao,et al.  Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction , 1999, Nature Genetics.